HIV/AIDS deaths in the U.S. have dropped significantly in recent years. In 1995, the death rate from HIV per 100,000 people was ****. That number has since decreased to *** per 100,000 as of 2023. The reduction in the HIV death rate in the U.S. can be attributed to an increase in access to HIV medications. HIV/AIDS in the U.S. Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) cause a systemic viral infection that damages the immune system. AIDS is a syndrome that is caused by HIV. AIDS is when the immune system is severely weakened by HIV and the body can no longer fight off infections. Among all U.S. states, Georgia, followed by Florida and Louisiana, had the highest rates of new HIV diagnoses in 2022. HIV/AIDS treatments in the U.S. HIV/AIDS treatments include antiretroviral medications to reduce the levels of HIV within the body. The largest funders for HIV/AIDS medications and research are the National Institutes of Health (NIH) and the Ryan White Program. The top HIV drug worldwide, based on revenue generated in 2023 was Biktarvy. Around the world, access to antiretroviral treatment has increased dramatically in recent years, a huge step in reducing the number of HIV-related deaths. There is currently no cure for HIV.

UNAIDS estimated that there were some ******* people worldwide that died from acquired immune deficiency syndrome (AIDS) in 2024. This statistic depicts the total number of annual AIDS-related deaths worldwide from 2000 to 2024. HIV/AIDS burden A majority of countries with the highest burden due to HIV and AIDS are in Africa- in 2024, the highest number of AIDS-related deaths occurred in South Africa and Mozambique and the highest prevalence of HIV was found in Eswatini. Although access to life-saving antiretroviral therapy treatment (ART) has increased globally over recent years, many individuals living with HIV still lack access to ART. Barriers and interventions In part due to the development of ART, the number of people living with HIV worldwide is continuing to increase, reaching almost ** million in 2024. Important public health measures to combat the burden of the disease include a combination of biomedical and behavioral interventions such as pre- and post-exposure prophylaxis, and context-specific structural interventions to reduce barriers to supplies and education. One prominent barrier faced by those living with HIV is stigma, which can often cause disadvantages in many areas of life, including employment, use of health services, and social support.

AIDS estimated deaths (UNAIDS estimates) in Guatemala was reported at 500 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Guatemala - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

AIDS estimated deaths (UNAIDS estimates) in Costa Rica was reported at 200 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Costa Rica - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

AIDS estimated deaths (UNAIDS estimates) in Namibia was reported at 3100 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Namibia - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

The states with the highest rates of HIV diagnoses in 2022 included Georgia, Louisiana, and Florida. However, the states with the highest number of people with HIV were Texas, California, and Florida. In Texas, there were around 4,896 people diagnosed with HIV. HIV/AIDS diagnoses In 2022, there were an estimated 38,043 new HIV diagnoses in the United States, a slight increase compared to the year before. Men account for the majority of these new diagnoses. There are currently around 1.2 million people living with HIV in the United States. Deaths from HIV The death rate from HIV has decreased significantly over the past few decades. In 2023, there were only 1.3 deaths from HIV per 100,000 population, the lowest rate since the epidemic began. However, the death rate varies greatly depending on race or ethnicity, with the death rate from HIV for African Americans reaching 19.2 per 100,000 population in 2022, compared to just three deaths per 100,000 among the white population.

AIDS estimated deaths (UNAIDS estimates) in Peru was reported at 970 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Peru - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

This scatter chart displays incidence of HIV (per 1,000 uninfected population) against death rate (per 1,000 people) in Bolivia. The data is about countries per year.

This scatter chart displays incidence of HIV (per 1,000 uninfected population) against death rate (per 1,000 people) in the Americas. The data is about regions.

AIDS estimated deaths (UNAIDS estimates) in Myanmar was reported at 6400 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Myanmar - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on June of 2025.

This scatter chart displays incidence of HIV (per 1,000 uninfected population) against death rate (per 1,000 people) in Sudan. The data is about countries per year.

IT: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data was reported at 7.200 NA in 2016. This records a decrease from the previous number of 7.300 NA for 2015. IT: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data is updated yearly, averaging 7.500 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 9.300 NA in 2000 and a record low of 7.200 NA in 2016. IT: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Italy – Table IT.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

Among all countries worldwide those in sub-Saharan Africa have the highest rates of HIV. The countries with the highest rates of HIV include Eswatini, South Africa, and Lesotho. In 2024, Eswatini had the highest prevalence of HIV with a rate of around ** percent. Other countries, such as Zimbabwe, have significantly decreased their HIV prevalence. Community-based HIV services are considered crucial to the prevention and treatment of HIV. HIV Worldwide The human immunodeficiency virus (HIV) is a viral infection that is transmitted via exposure to infected semen, blood, vaginal and anal fluids, and breast milk. HIV destroys the human immune system, rendering the host unable to fight off secondary infections. Globally, the number of people living with HIV has generally increased over the past two decades. However, the number of HIV-related deaths has decreased significantly in recent years. Despite being a serious illness that affects millions of people, medication exists that effectively manages the progression of the virus in the body. These medications are called antiretroviral drugs. HIV Treatment Generally, global access to antiretroviral treatment has increased. However, despite being available worldwide, not all adults have access to antiretroviral drugs. There are many different antiretroviral drugs available on the market. As of 2024, ********, an antiretroviral marketed by Gilead, was the leading HIV treatment based on revenue.

AIDS estimated deaths (UNAIDS estimates) in Haiti was reported at 1600 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Haiti - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

BackgroundInfectious diseases remain one of the leading causes of death among children worldwide. This study aims to analyze the burden and trends of infectious diseases among children aged 0–14 years in China from 1990 to 2021, and evaluate their gender- and age-specific impacts.MethodsThis study utilizes data from the Global Burden of Disease (GBD) 2021 to analyze mortality, incidence, disability-adjusted life years (DALYs), age-standardized mortality rates (ASMR), age-standardized incidence rates (ASIR), and age-standardized DALY rates (ASDR) for infectious diseases in Chinese children. Statistical analysis was performed using R and ggplot2.ResultsFrom 1990 to 2021, China observed substantial declines in pediatric infectious disease burdens. Acute hepatitis mortality decreased from 7,349 deaths (95% UI:5,987–9,059) to 87 (EAPC: −13.78), with a fivefold reduction in ASMR. Enteric infections exhibited the steepest decline: incidence dropped by 86% (EAPC: −6.72), and ASDR fell from 2,257 to 67/100,000. HIV/AIDS deaths rose from 62 to 555 (EAPC:8.28), though post-2018 declines emerged. By 2021, lower respiratory infections remained the leading cause of death (ASMR:5.11/100,000), while upper respiratory infections had the highest incidence. Females showed faster reductions in enteric (EAPC: −7.44 vs. −6.20) and lower respiratory infections (EAPC: −10.39 vs. −9.76). Children under 5 faced the highest burden, particularly for lower respiratory infections (ASMR:13.02/100,000).ConclusionThe overall burden of infectious diseases among children in China has declined, especially for enteric infections and acute hepatitis. The burden of pediatric HIV/AIDS has also decreased in recent years, though adolescent HIV/AIDS education remains a key area of concern. Children under 5 continue to represent the highest burden group. While China’s infectious disease control measures and immunization programs have played a vital role, further strengthening policies to address ongoing challenges is essential for effectively reducing the burden of infectious diseases and achieving the Healthy China 2030 goals.

This table presents a wide variety of historical data in the field of health, lifestyle and health care. Figures on births and mortality, causes of death and the occurrence of certain infectious diseases are available from 1900, other series from later dates. In addition to self-perceived health, the table contains figures on infectious diseases, hospitalisations per diagnosis, life expectancy, lifestyle factors such as smoking, alcohol consumption and obesity, and causes of death. The table also gives information on several aspects of health care, such as the number of practising professionals, the number of available hospital beds, nursing day averages and the expenditures on care. Many subjects are also covered in more detail by data in other tables, although sometimes with a shorter history. Data on notifiable infectious diseases and HIV/AIDS are not included in other tables.

Data available from: 1900

Status of the figures: Most figures are definite. Figures are provisional for the last year reported for: - hospital admissions; - health professions. Figures are revised provisional for the last two years reported for: - expenditures on care. Due to "dynamic" registrations, figures for infectious diseases remain provisional.

Changes as of 29 December 2017: - For each series the most recent available figures have been added - Figures on HIV-infections have been updated over the entire range by the HIV Monitoring Foundation.

Changes as of 22 December 2016: - For each series the most recent available figures have been added - Health expenditure as percentage of bdp has been changed for 1974, 1977, 1981 and 1984.

When will new figures be published? December 2018.

AIDS estimated deaths (UNAIDS estimates) in Vietnam was reported at 4100 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Vietnam - AIDS estimated deaths (UNAIDS estimates) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

This scatter chart displays death rate (per 1,000 people) against incidence of HIV (per 1,000 uninfected population) in Panama. The data is filtered where the date is 2021. The data is about countries per year.

This table shows the wide variety of long-term series in the field of health, lifestyle and healthcare. Figures on births and deaths, some causes of death and the occurrence of certain infectious diseases are available from 1900. Other series start at a later date. In addition to perceived health, the table includes figures on infectious diseases, hospital admissions by diagnosis, life expectancy, lifestyle factors such as smoking, alcohol and overweight, and causes of death. Various aspects of health care such as the number of healthcare professionals, the number of available hospital beds, the average length of stay and expenditure on care are also included in the table. Many topics are also listed in more detail in other StatLine tables, but sometimes with a shorter duration. Data on notifiable infectious diseases and AIDS/HIV are not included in other tables. Data available from: 1900 Status of the figures: Most figures are final. The most recently added year is provisional for: - diagnoses at hospital admission; - quantitative data from hospitals - healthcare professions; - causes of death. For expenditure on care, the figures for 2022 are provisional; the figures for 2020 and 2021 are more provisional; the other figures are final. All years are provisional for: notifiable infectious diseases, HIV, AIDS. Changes as of July 7, 2023: - Supplement with the most recent figures available. Changes as of 14 July 2022: - Replacement of the series of volume indices for healthcare expenditure with reference year 2010 for a new series with reference year 2015. When will new figures be released? The most recent figures available at that time will be published in December 2023.